|
1) Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991; 324: 1297-304
|
|
|
|
2) Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000; 96: 2049-54
|
|
|
|
|
|
3) Gluckman E, Rokicka-Milewska R, Hann I, et al. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. Br J Haematol. 2002; 119: 1075-82
|
|
|
|
|
4) Teramura M, Kimura A, Iwase S, et al. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood. 2007; 110: 1756-61
|
|
|
|
|
|
5) Schrezenmeier H, Passweg JR, Marsh JC, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007; 110: 1397-400
|
|
|
|
|
|
6) Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997; 336: 897-904
|
|
|
|
|
|
7) Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002; 100: 799-803
|
|
|
|
|
|
8) Yagasaki H, Kojima S, Yabe H, et al. Improved outcome of unrelated bone marrow transplantation for severe aplastic anemia. Blood. 2007; 110: 897a
|
|
|
|
|
|
9) Kojima S, Yoshimi A, Taniguchi S, et al. Unrelated cord blood cell transplantation for acquired severe aplastic anemia: The report from the Japan Cord Blood Bank Network. Blood. 2007; 110: 601a
|
|
|
|
|
|
10) Bayever E, Champlin R, Ho W, et al. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. Pediatrics. 1984; 105: 920-25
|
|
|
|
|
|
11) Halperin DS, Grisaru D, Freedman MH, et al. Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy. Am J Pediatr Hematol Oncol. 1989; 11: 304-9
|
|
|
|
|
|
12) Locasciulli A, van't Veer L, Bacigalupo A, et al. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party. Bone Marrow Transplant. 1990; 6: 211-7
|
|
|
|
|
|
13) Kojima S, Horibe K, Inaba J, et al. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol. 2000; 111: 321-8
|
|
|
|
|
|
14) Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003; 289: 1130-5
|
|
|
|
|
|
15) Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003; 101: 1236-42
|
|
|
|
|
|
16) Ohara A, Kojima S, Kobayashi R, et al. 10-Year-outcome of acquired aplastic anemia children treated with antithymocyte globulin, cyclosporine with or without G-CSF. Blood. 2006; 108: 41a
|
|
|
|
|
|
17) Scheinberg P, Wu CO, Nunez O, et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatrics. 2008; 153: 814-9
|
|
|
|
|
|
18) Kobayashi R, Yabe H, Hara J, et al. Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. Br J Haematol. 2006; 135: 693-6
|
|
|
|
|
|
19) Kosaka Y, Yagasaki H, Sano K, et al. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood. 2008; 111: 1054-9
|
|
|
|
|